Akanda Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement
June 14, 2024
London, United Kingdom–(Newsfile Corp. – June 14, 2024) – Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, […]
Akanda Corporation Announces Completion of F-3 Shelf Registration Statement
June 14, 2024
London, United Kingdom–(Newsfile Corp. – June 14, 2024) – Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, […]
Akanda Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement
June 12, 2024
London, United Kingdom–(Newsfile Corp. – June 12, 2024) – Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, […]
Akanda Announces Stock Consolidation
May 21, 2024
London, United Kingdom–(Newsfile Corp. – May 21, 2024) – Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, […]
Akanda Announces Closing of Subsequent Registered Direct Offering
May 20, 2024
London, United Kingdom–(Newsfile Corp. – May 20, 2024) – Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, […]
Akanda Corp. Announces Signing of Option to Develop Canadian THC and CBD Farming Facility
September 20, 2023
FRANKFURT, Germany & LONDON–(BUSINESS WIRE)– International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN, WKN: A3DG83) announces that Akanda (the “Optionee” […]
Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
July 6, 2023
LONDON–(BUSINESS WIRE)– International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced that the Company has received a […]
Akanda Corp. Announces Termination of Loan Agreement
May 26, 2023
FRANKFURT, Germany & LONDON–(BUSINESS WIRE)– International Medical Cannabis Company, Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN, WKN: A3DG83) announces that Akanda and Veridia […]
Akanda Corp. Announces Loan Agreement
April 28, 2023
FRANKFURT, Germany & LONDON–(BUSINESS WIRE)– International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN, WKN: A3DG83) announces that it has […]
Akanda Corporation Has Regained Compliance with NASDAQ’s Minimum Bid Price Requirement
March 29, 2023
LONDON–(BUSINESS WIRE)– International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) an Ontario company, today announced that it received […]
Akanda Corporation Announces 1-for-10 Reverse Stock Split
March 8, 2023
LONDON–(BUSINESS WIRE)– International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) an Ontario company, reported that it expects to […]
Akanda Corporation Announces CFO Appointment
March 7, 2023
LONDON–(BUSINESS WIRE)– International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) an Ontario company, reported that it has appointed […]